RAPT
RAPT Therapeutics Inc
NASDAQ: RAPT · HEALTHCARE · BIOTECHNOLOGY
$58.02
+0.00% today
Updated 2026-03-04
Market cap
$1.68B
P/E ratio
—
P/S ratio
411.22x
EPS (TTM)
$-11.66
Dividend yield
—
52W range
$6 – $58
Volume
3.2M
RAPT Therapeutics Inc (RAPT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-0.85%
ROA
-0.51%
Debt/equity
0.02x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-29.11M | — | — | — |
| 2018 | $0.00 | $-36.15M | — | — | — |
| 2019 | $935000.00 | $-43.00M | -142.25% | -4,666.20% | -4,598.61% |
| 2020 | $5.04M | $-52.89M | 100.00% | -1,055.41% | -1,049.03% |
| 2021 | $3.81M | $-68.21M | 100.00% | -1,815.08% | -1,788.83% |
| 2022 | $1.53M | $-81.88M | 100.00% | -5,618.53% | -5,362.21% |
| 2023 | $0.00 | $-116.80M | — | — | — |
| 2024 | $0.00 | $-129.87M | — | — | — |